Myocardial contractile response to nitric oxide and cGMP

Circulation

Volumn 93, Issue 6, 1996, Pages 1223-1229

  Mohan, Puneet ^a   Brutsaert, Dirk L ^a   Paulus, Walter J ^b   Sys, Stanislas U ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b CARDIOVASCULAR CENTER   (Belgium)

Author keywords

contractility; endocardium; endothelium; myocardium; nitric oxide

Indexed keywords

8 BROMOGUANOSINE PHOSPHATE; CYCLIC GMP; LINSIDOMINE; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; ZAPRINAST;

ADRENERGIC STIMULATION; ANIMAL TISSUE; ARTICLE; CAT; CHOLINERGIC STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOCARDIUM; ENDOTHELIUM; HEART CONTRACTION; HEART PAPILLARY MUSCLE; INOTROPISM; MUSCLE ISOMETRIC CONTRACTION; MUSCLE ISOTONIC CONTRACTION; NONHUMAN; PRIORITY JOURNAL;

EID: 0029968144     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.93.6.1223     Document Type: Article

References (63)

1. Brutsaert DL, Meulemans AL, Sipido KR, Sys SU. Effects of damaging endocardial surface on the mechanical performance of isolated cardiac muscle. Circ Res. 1988;62:358-366.
2. Smith JA, Shah AM, Lewis MJ. Factors released from endocardium of the ferret and pig modulate myocardial contraction. J Physiol (Lond). 1991;439:1-14.
3. Li KH, Rouleau JL, Andries LJ, Brutsaert DL. Effect of dysfunctional vascular endothelium on myocardial performance in isolated papillary muscles. Circ Res. 1993;72:768-777.
4. Ramaciotti C, McClellan G, Sharkey A, Rose D, Weisberg A, Winegrad S. Cardiac endothelial cells modulate contractility of rat heart in response to oxygen tension and coronary flow. Circ Res. 1993;72:1044-1064.
5. Paulus WJ, Vantrimpont PJ, Shah AM. Paracrine coronary endothelial control of left ventricular function in humans. Circulation. 1995;92:2119-2126.
6. Schulz R, Smith JA, Lewis MJ, Moncada S. Nitric oxide synthase in cultured endocardial cells of the pig. Br J Pharmacol. 1991;104:21-24.
7. 2. J Mol Cell Cardiol. 1993; 25:245-248.
8. Mebazaa A, Mayoux E, Maeda K, Martin LD, Lakatta EG, Robotham JL, Shah AM. Paracrine effects of endocardial endothelial cells on myocyte contraction mediated via endothelin. Am J Physiol. 1993;265:H1841-H1846.
9. Shah AM, Mebazaa A, Wetzel RC, Lakatta EG. Novel cardiac myofilament desensitizing factor released by endocardial and vascular endothelial cells. Circulation. 1994;89:2492-2497.
10. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991;43:109-142.
11. Meulemans AL, Sipido KR, Sys SU, Brutsaert DL. Atriopeptin III induces early relaxation of ventricular cardiac muscle. Cirr Res. 1988;62:1171-1174.
12. Balligand JL, Kelly RA, Marsden PA, Smith TW, Michel T. Control of cardiac muscle cell function by an endogenous nitric oxide signalling system. Proc Natl Acad Sci USA. 1993;90:347-351.
13. Brady AJ, Warren JB, Poole-Wilson PA, Williams TJ, Harding SE. Nitric oxide attenuates cardiac myocyte contraction. Am J Physiol. 1993;265:H176-H182.
14. Finkel MS, Oddis CV, Mayer OH, Hattler BG, Simmons RL. Nitric oxide synthase inhibitor alters papillary muscle force-frequency relationship. J Pharmacol Exp Ther. 1995;272:945-952.
15. Weyrich AS, Xin-Liang M, Buerke M, Murohara T, Armstead VE, Lefer AM, Nicolas JM, Thomas AP, Lefer DJ, Vinten-Johansen J. Physiological concentrations of nitric oxide do not elicit an acute negative inotropic effect in unstimulated cardiac muscle. Circ Res. 1994;75:692-700.
16. Paulus WJ, Vantrimpont PJ, Shah AM. Acute effects of nitric oxide on left ventricular relaxation and diastolic distensibility in humans: assessment by bicoronary sodium nitroprusside infusion. Circulation. 1994;89:2070-2078.
17. G-Monomethyl-L-arginine (NMA) restores arterial blood pressure but reduces cardiac output in a canine model of endotoxic shock. Biochem Biophys Res Commun. 1991;178:1135-1140.
18. Klahunde RE, Ritger RC, Helgren MC. Cardiovascular actions of inhibitors of endothelium-derived relaxing factor (nitric oxide) formation/release in anesthetized dogs. Eur Pharmacol. 1991;199:51-59.
19. Richard V, Bordeaux A, la Rochelle CD, Guidicelli J-F. Regional coronary hemodynamic effects of two inhibitors of nitric oxide synthesis in anesthetized, open chest dogs. Br J Pharmacol. 1991; 104:59-64.
20. Hasche N, Shen YT, Vatner SF. Inhibition of endothelium-derived relaxing factor enhances myocardial stunning in conscious dogs. Circulation. 1993;88:2862-2871.
21. Stamler JS, Loh E, Roddy MA, Currie KE, Creager MA. Nitric oxide regulates basal systemic and pulmonary vascular resistance in healthy humans. Circulation. 1994;89:2035-2040.
22. Lohmann SM, Fischmeister R, Walter U. Signal transduction by cGMP in heart. Basic Res Cardiol. 1991;86:503-514.
23. Goldberg ND, Haddox MK, Nichol SE, Glass DB, Sanford CH, Kuehl FA, Estenssen R. Biological regulation through opposing influences of cyclic GMP and cyclic AMP: the yin-yang hypothesis. Adv Cyclic Nucleotide Res. 1975;5:307-330.
24. George WJ, Polson JB, O'Toole AG, Goldberg ND. Elevation of cGMP in rat heart after perfusion with acetylcholine. Proc Natl Acad Sci USA. 1970;66:398-403.
25. Kuo JF, Lee TP, Reyes PL, Walton KG, Donnely TE. Greengard P. Cyclic nucleotide-dependent protein kinases, X: an assay method for the measurement of cGMP in various biological materials and a study of agents regulating its level in heart and brain. J Biol Chem. 1972;247:16-22.
26. Watanabe AM, Besch HR. Interaction between cAMP and cGMP in guinea pig ventricular myocardium. Circ Res. 1975;37:309-317.
27. Lincoln TM, Keely SL. Regulation of cardiac cyclic GMP-dependent protein kinase. Biochim Biophys Acta. 1981;676:230-244.
28. Dobson JG. The effect of acetylcholine, ischemia, and anoxia on rat heart purine cyclic nucleotides and contractility. Circ Res. 1981;49: 912-922.
29. Flitney FW, Singh J. Evidence that cyclic GMP may regulate cyclic AMP metabolism in the isolated frog ventricle. J Mol Cell Cardiol. 1981;13:963-979.
30. Linden J, Brooker G. The questionable role of cGMP in heart. Biochem Pharmacol. 1979;28:3351-3360.
31. Brooker G. Dissociation of cGMP from the negative inotropic action of carbachol in guinea pig atria. J Cyclic Nucleotide Res. 1977; 3:407-413.
32. Diamond J, Ten Eick RE, Trapani AJ. Are increases in cGMP levels responsible for the negative inotropic effects of acetylcholine in the heart? Biochem Biophys Res Commun. 1977;79:912-917.
33. Diamond J, Chu EB. A novel cyclic GMP-lowering agent LY 83583 blocks carbachol-induced cyclic GMP elevation in rabbit atrial strips without blocking the negative inotropic effect of carbachol. Can J Physiol Pharmacol. 1985;63:908-911.
34. Katsuki S, Arnold WP, Murad F. Effects of sodium nitroprusside, nitroglycerin and sodium azide on levels of cyclic nucleotides and mechanical activity in various tissues. J Cyclic Nucleotide Res. 1977; 3:239-247.
35. Endoh M, Yamashita S. Differential responses to carbachol. sodium nitroprusside and 8-bromo-cGMP of canine atrial and ventricular muscle. Br J Pharmacol. 1981;73:393-399.
36. Trautwein W, Trube G. Negative inotropic effect of cGMP in cardiac fibre fragments. Pflugers Arch. 1976;366:293-295.
37. Wilkerson RD, Paddock RJ, George WJ. Effects of cyclic AMP and cyclic GMP on contraction force of cat papillary muscles. Eur J Pharmacol. 1976;36:247-251.
38. Nawrath H. Cyclic AMP and cyclic GMP may play opposing roles in influencing force of contraction in mammalian myocardium. Nature. 1976;262:509-511.
39. Kohlhardt M, Haap K. 8-Bromo-cGMP mimics the effect of acetylcholine on slow response action potential and contractile force in mammalian atrial myocardium. J Mol Cell Cardiol. 1978;10:573-586.
40. Singh J, Flitney FW. Inotropic responses of the frog ventricle to dibutyryl cyclic AMP and 8-bromo-cGMP and related changes in endogenous cyclic nucleotide levels. Biochem Pharmacol. 1981;30: 1475-1481.
41. Shah AM, Lewis MJ, Henderson AH. Effects of 8-bromo-cGMP on contraction and on inotropic response of ferret cardiac muscle. J Mol Cell Cardiol. 1991;23:55-64.
42. 2+ in intact cardiac myocytes. Circ Res. 1994;74:970-978.
43. Endoh M, Shimizu T. Failure of dibutyryl-cAMP and 8-bromo-cGMP to mimic the antagonistic action of carbachol on the positive inotropic effects of sympathomimetic amines in the canine isolated ventricular myocardium. Jpn J Pharmacol. 1979;29:423-433.
44. Goldberg ND, Haddox MK. Cyclic GMP metabolism and involvement in biological regulation. Annu Rev Biochem. 1977;46: 823-896.
45. Lincoln TM, Corbin JD. Characterization and biological role of the cGMP-dependent protein kinase. Adv Cyclic Nucleotide Rex. 1983; 15:139-193.
46. Fischmeister R, Hartzell HC. Cyclic GMP regulates the calcium current in single cells from frog ventricle. J Physiol (Lond). 1987; 387:453-472.
47. Meulemans AL, Sipido KR, Sys SU, Brutsaert DL. Atriopeptin III induces early relaxation of ventricular cardiac muscle. Circ Res. 1988;62:1171-1174.
48. Dundore RL, Habeeb PG, Pratt PF, Becker LT, Clas DM, Buchholz RA. Differential hemodynamic responses to selective inhibitors of cyclic nucleotide phosphodiesterases in conscious rats. J Cardiovasc Pharmacol. 1992;19:937-944.
49. Trapani AJ, Smits GJ, McGraw DE, McMahon EG, Blaine EH. Hemodynamic basis for the depressor activity of zaprinast, a selective cyclic GMP phosphodiesterase inhibitor. J Pharmacol Exp Ther. 1991;258:269-274.
50. 2+ current in guinea-pig ventricular cells. J Physiol (Lond). 1991;443:387-404.
51. Beavo JA, Reifsnyder DH. Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors. Trends Pharmacol Sci. 1990;11:150-155.
52. Walter U. Physiological role of cGMP and cGMP-dependent protein kinase in the cardiovascular system. Rev Physiol Biochem Pharmacol. 1989;113:42-48.
53. Levi RC, Alloatti G, Fischmeister R. Cyclic GMP regulates the Ca-channel current in guinea pig ventricular myocytes. Pflugers Arch. 1989;413:685-687.
54. 2+ current is regulated by cyclic GMP-dependent protein kinase in mammalian cardiac myocytes. Proc Natl Acad Sci USA. 1991;88:1197-1201.
55. Pfitzer G, Ruegg JC, Flockerzi V, Hofmann F. Cyclic GMP protein kinase decreases calcium sensitivity of skinned cardiac fibres. FEBS Lett. 1982;149:171-175.
56. 2+ release in sea urchin egg homogenates: modulation by cyclic ADP-ribose. Science. 1991;253:1143-1146.
57. Cheung Lee H. A signalling pathway involving cyclic ADP-ribose, cGMP, and nitric oxide. News Physiol Sci. 1994;9:134-137.
58. 2+ channel. Nature. 1993;364:76-79.
59. 2+ in sea urchin eggs by stimulating cyclic ADP-ribose synthesis. Nature. 1993;365:456-459.
60. 2+ current: involvement of cGMP-inhibited and cGMP-stimulated phosphodiesterases through guanyl cyclase activation. J Biol Chem. 1993;268:26286-26295.
61. Dollinger SJ, Wahler GM. A nitric oxide donor has stimulatory and inhibitory effects on the cardiac calcium current, both of which are inhibited by a G-kinase blocker. Biophys J. 1994;66:A238. Abstract.
62. Mohan P, Brutsaert DL, Sys SU. Myocardial performance is modulated by interaction of cardiac endothelium-derived nitric oxide and prostaglandins. Cardiovasc Res. 1995;29:637-640.
63. Li K, Stewart DJ, Rouleau J-L. Myocardial contractile actions of endothelin-1 in rat and rabbit papillary muscles: role of endocardial endothelium. Circ Res. 1991;69:301-312.